Monoclonal Antibody — What It Means in Clinical Trials
Plain English Definition
A monoclonal antibody is a laboratory-made protein designed to attach to a specific target on cells, like a lock-and-key system. These targets are often proteins found on cancer cells or immune cells. Monoclonal antibodies can mark cancer cells for destruction, block growth signals, or deliver drugs directly to tumors. Drug names ending in "-mab" are monoclonal antibodies.
Why It Matters
Many of the newest cancer drugs are monoclonal antibodies. They are usually given as infusions at a clinic, so trial participation may involve regular clinic visits for treatment.
Example
A listing might mention: "Trastuzumab (a monoclonal antibody targeting HER2) combined with chemotherapy." The "-mab" ending tells you it is a monoclonal antibody.
Need help understanding eligibility criteria?
How to Read Eligibility Criteria →